Novartis Opens New Radioligand Therapy Manufacturing Facility in California to Boost U.S. Cancer Treatment Capacity Read more
Lyell Immunopharma Boosts Solid Tumor Pipeline with Acquisition of Promising CAR T Therapy for Colorectal Cancer Read more
Novo Nordisk Showcases OASIS 4 Data Highlighting Broader Health Benefits of Oral Semaglutide 25 mg Read more
FDA Approves Johnson & Johnson’s DARZALEX FASPRO as First Treatment for High-Risk Smoldering Multiple Myeloma Read more
FDA Clears Jupiter Neurosciences’ IND to Launch Phase 2a Trial of JOTROL for Parkinson’s Disease Read more